<html>
<head>PUBMED IDs for EIF-5A</head>
<body bgcolor='#C5F0F2'><h1>EIF-5A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10803608/'>Protein expression strategies for identification of novel target proteins.</a> May 10  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/17949776/'>Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.</a> October 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17949714/'>A regulatory perspective on the development of gene therapy for Parkinson's disease.</a> October 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19054548/'>Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.</a> December 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19298601/'>Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.</a> June 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23505486/'>Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton.</a> September 7  2013<br></body></html>
